April 1st 2025
Semaglutide 2.4 mg significantly lowered the risk of MACE and mortality in patients with ASCVD and overweight or obesity but without diabetes, researchers reported.
COVID-19 Vaccination Safe in Patients with Previous Myocarditis, According to New Research
March 17th 2022Adults with previous acute myocarditis did not experience recurrence or serious adverse events after COVID-19 vaccination in a small study presented at ESC Acute CardioVascular Care Congress 2022.
Burden of Atrial Fibrillation in Patients with Ischemic Stroke is Substantial According to New Study
February 11th 2022Atrial fibrillation-related ischemic stroke may be a factor in hospital deaths among over 50% of older adults, suggests new findings presented at the International Stroke Conference.